United States · FDA National Drug Code directory

Pepto Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
17714-045_60f4322f-5cb1-096a-e053-2a91aa0a64eb
Product NDC
17714-045
Form
TABLET, CHEWABLE
Composition / generic term
Bismuth subsalicylate
Labeler
Advance Pharmaceutical Inc.
Marketing category
OTC MONOGRAPH FINAL
Marketing start / end (source format)
20020109
Source listing expiry
20261231

Source-listed ingredients

  • BISMUTH SUBSALICYLATE — 262 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, CHEWABLE in 1 BOTTLE (17714-045-30) · 17714-045-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →